iOMEDICO
Private Company
Total funding raised: $40M
Overview
iOMEDICO is a specialized, oncology-focused CRO and research institute that bridges clinical practice with advanced research. It operates a dual model, providing full-service clinical trial management while also developing proprietary digital health platforms, including electronic data capture (EDC) systems and AI-powered tools for clinical research and real-world data analysis. The company's unique position is strengthened by its deep investigator network, focus on real-world evidence, and government-funded AI projects, positioning it at the intersection of clinical research and digital innovation in oncology.
Technology Platform
Proprietary Electronic Data Capture (EDC) systems, study portals, and AI-powered platforms for clinical trial management (eTMF) and pattern recognition in oncology registry data (NIO project). Focus on digitizing trials and analyzing real-world evidence.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with large, global full-service CROs (e.g., IQVIA, PPD, ICON) and specialized oncology CROs. Also faces emerging competition from tech companies and RWE analytics firms. Its differentiation lies in its deep oncology specialization, integrated digital platform, and unique real-world data access via its community-based network.